InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

CK

Code Kenneth Reay

Other

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Code Kenneth Reay. Director active across 1 company, notably Biolargo, INC.. In total, 14 filings have been recorded. Activity tracked since 5 October 2021. The latest transaction was disclosed on 7 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Code Kenneth Reay

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Biolargo, INC. (US)

Declarations14 total

◆

CODE KENNETH REAY

Chief Science OfficerExecutives7 Jul 2026Biolargo, INC.

$60,44636SEC ↗

532,567 shares@ US$0.11350.17% mcap28.6% of flowCommon StockSEC:0001437749-26-022951:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Mar 2026Biolargo, INC.

$11,25025SEC ↗

69,444 shares@ US$0.1625.0% of flowCommon StockSEC:0001437749-26-011170:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Dec 2025Biolargo, INC.

$10,10025SEC ↗

54,803 shares@ US$0.18433.3% of flowCommon StockSEC:0001437749-26-000429:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives14 Nov 2025Biolargo, INC.

$50,20127SEC ↗

313,754 shares@ US$0.1616.9% of flowCommon StockSEC:0001437749-25-035504:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives14 Jul 2025Biolargo, INC.

$36,25126SEC ↗

181,253 shares@ US$0.2014.6% of flowCommon StockSEC:0001437749-25-022850:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Dec 2024Biolargo, INC.

$10,95726SEC ↗

57,666 shares@ US$0.198.0% of flowCommon stockSEC:0001437749-25-000351:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Dec 2023Biolargo, INC.

$12,20026SEC ↗

72,621 shares@ US$0.1688.4% of flowCommon stockSEC:0001437749-24-000496:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives30 Sept 2023Biolargo, INC.

$3,15025SEC ↗

19,010 shares@ US$0.16572.3% of flowCommon stockSEC:0001437749-23-027572:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives30 Jun 2023Biolargo, INC.

$12,20026SEC ↗

68,541 shares@ US$0.1788.5% of flowCommon stockSEC:0001437749-23-019410:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Mar 2023Biolargo, INC.

$6,30025SEC ↗

30,747 shares@ US$0.20494.4% of flowCommon stockSEC:0001437749-23-009344:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives3 Oct 2022Biolargo, INC.

$45,30128SEC ↗

167,781 shares@ US$0.2734.9% of flowCommon stockSEC:0001437749-22-023721:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives30 Jun 2022Biolargo, INC.

$19,40126SEC ↗

107,784 shares@ US$0.1814.0% of flowCommon stockSEC:0001437749-22-016650:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives31 Dec 2021Biolargo, INC.

$3,15011SEC ↗

15,000 shares@ US$0.211.1% of flowCommon stockSEC:0001437749-22-000330:0

◆

CODE KENNETH REAY

Chief Science OfficerExecutives5 Oct 2021Biolargo, INC.

$11,75011SEC ↗

61,842 shares@ US$0.193.8% of flowCommon stockSEC:0001437749-21-023395:0

14 of 14 declarations

About Code Kenneth Reay

CODE KENNETH REAY is a declarant linked to Biolargo, INC. (XNAS), where the listed role is Chief Science Officer. He has 14 filings in total, and across the sampled recent filings the period runs from 2021-10-06 to 2026-07-07, with attribution transactions rather than buys or sells.